期刊文献+

IL-1β对人冠脉平滑肌细胞基质金属蛋白酶-3及基质金属蛋白酶组织抑制剂-1表达的影响

Effect of IL-1β on the expressions of MMP-3 and TIMP-1 genes in human coronary artery smooth muscle cells
暂未订购
导出
摘要 目的探讨炎症因子IL-1β对人冠脉平滑肌细胞表达平滑肌细胞基质金属蛋白酶-3(MMP-3)和基质金属蛋白酶组织抑制剂-1(TIMP-1)的影响。方法①应用20μg/L浓度的IL-1β刺激人冠脉平滑肌细胞,分别在共同培养0、2、4、8、24、36 h后收集细胞;②应用不同浓度的IL-1β(0、5、20、40μg/L)刺激人冠脉平滑肌细胞,共同培养6 h后收集细胞;③应用实时荧光定量PCR的方法检测细胞内MMP-3和TIMP-1基因的表达量。结果同剂量IL-1β刺激下,MMP-3的表达量在2 h时就开始发生上调,8 h达高峰,而后开始下降;在不同剂量IL-1β刺激下,MMP-3的表达量在实验剂量范围内随着IL-1β的剂量加大呈上升趋势。而TIMP-1表达量在2 h时就开始发生下调,8 h达最低,而后开始上升;在不同剂量IL-1β刺激下,TIMP-1的表达量在实验剂量范围内随着IL-1β的剂量加大呈下降趋势。结论炎症因子IL-1β能促进冠脉平滑肌细胞中斑块稳定相关标记物MMP-3、TIMP-1的表达,可能是炎症在急性冠脉综合征的发生发展中起重要作用的机制之一。 Objective To elevate the effect of IL-1β on the expressions of MMP-3 and TIMP-1 genes in human coronary artery smooth muscle cells. Methods Human coronary artery smooth muscle cells were stimulated with IL-1β (20 μg/L), RNA were isolate and culture media were collected after 0,2,4,8,24 and 36 h. Then human coronary artery smooth muscle cells were stimulated with IL-1β(0,5,20,40 μg/ L) respectively, Isolate RNA and collect culture media after 6 h. Real-time PCR was performed on RNA to detect MMP-3 ,TIMP-1 gene expressions. Results (1)In the groups of same dose, MMP-3 gene expressions were up-regulated at 2 h, and at 8 h the expressions got to peak, then began to descent;in groups of different dose of IL-1β, MMP-3 gene expressions were up-regula dose, TIMP-1 gene expressions were down-regulated at 2 h, and ted with the dose. (2)In the groups of same at 8 h the gene expressions got to lowest, then began to go up; in groups of different dose of IL-1β, TIMP-1 gene expressions were down-regulated with the dose. Conclusion It suggested that IL-1β can promote MMP-3 gene expressions and inhibit TIMP-1 gene expressions in human coronary artery smooth muscle cells, and it may be one of the mechanisms of inflammation effect in acute coronary syndrome.
机构地区 解放军 解放军
出处 《哈尔滨医科大学学报》 CAS 北大核心 2008年第4期344-347,共4页 Journal of Harbin Medical University
基金 全军医药卫生"十五"计划重点课题(04LX048) 全军医药卫生"十一五"计划科技攻关课题(06G144)
关键词 急性冠脉综合征 白细胞介素-1Β 基质金属蛋白酶-3 金属蛋白酶组织抑制剂-1 炎症 acute coronary syndrome interleukin-1β matrix metalloproteinase-3 issue inhibitor of metal-loproteinase-1 inflammation
  • 相关文献

参考文献11

  • 1Ross R. Atherosclerosis-an inflammatory disease [ J ]. N Engl J Med,1999,340(2) :115-126.
  • 2Biasucci LM, Colizzi C, Rizzello V, et al. Role of inflammation in the pathogenesis of unstable coronary artery diseases [ J ]. Scand J Clin Lab Invest, 1999,230 : 12-22.
  • 3Shah PK, Moreno P, Falk E. Pathophysiology of plaque rupture [ J ]. Vasc Med Biol, 1995,5:224-258.
  • 4Davies MJ. Pathophysiology of acute coronary syndrome[ J]. Indian Heart J,2000,52(4) :473-479.
  • 5程翔,廖玉华.炎症与动脉粥样硬化[J].中华心血管病杂志,2004,32(5):475-477. 被引量:89
  • 6Galis S, Sukhova GK, Lark MW, et al. Increase expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques [ J ]. J Clin Invest, 1994,94 (6) :2493-2503.
  • 7Shah PK, Falk E, Badinom J J, et al. Human monocyte-derived macrophages induce collagen breaddown in fibrous caps of atherosclerotic plaque: Potential role of matrix degrading metalloproteinases and implications for plaque rupture [ J ]. Circulation, 1995,92 (8) : 1565-1569.
  • 8Pasterkamp G, Schoneveld AH, Hijnen D J, et al. Atherosclerotic arterial remodeling and the localization of macrophages and matrix metalloproteases1 ,2 and 9 in the human coronary artery [ J ]. Atherosclerosis, 2000,150 ( 2 ) :245-253.
  • 9Galis ZS,Sukhova GK,Kranzhofer R,et al. Macrophage foam cells from experimental atheroma constitutively produce matrix-degrading proteinases [ J ].Proc Natl Acad Sci USA, 1995,92 (2) :402-406.
  • 10张涛,郝玉明.基质金属蛋白酶与冠心病[J].临床内科杂志,2005,22(1):13-15. 被引量:16

二级参考文献7

  • 1Shah PK. Role of inflammation and metall oproteinases in plaque disruption and thrombosis. Vasc Med 1998: 3(3):199-206.
  • 2Pasterkamp G, Schoneveld AH, vander Wal AC, et al. Inflammation of the atherosclerotic cap and shoulder of the plaque is a common and locally observed feature in unruptured plaques of femoral and coronary arteries. Arterioscler Thromb Vasc Biol 1999; 19(1): 54-8.
  • 3Pearson TA, Mensah GA, Alexander RW, et al. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for heal thcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 2003; 107(3):499-521.
  • 4Beaudeux JL, Giral P, Bernard M, et al. Serum matrix metalloproteinase-3 and tissue inhibitor of metlloproteinases-1 as potential markers of carotid atherosclerosis in infraclinical hyperlipidemia. Atherosclerosis 2003; 169(1):139-46.
  • 5Kai H, Ikeda H, Yasukawa H, et aL Peripheral blood levels of matrixmetallopro-teases-2 and-9 are elevated in patients with acute coronary syndromes. J Am Coll Cardiol 1998; 32(2): 368-72.
  • 6Bayes-Genis A, Conover CA, Overgaard MT, et al. Pregnancy-associated plas maprotein A as a marker of acute coronary syndromes. N Engl J Med 2001; 345(14): 1022-9.
  • 7Alicja Wiercinska-Drapalo,Jerzy Jaroszewicz,Robert Flisiak,Danuta Prokopowicz.Plasma matrix metalloproteinase-1 and tissue inhibitor of metalloproteinase-1 as biomarkers of ulcerative colitis activity[J].World Journal of Gastroenterology,2003,9(12):2843-2845. 被引量:23

共引文献106

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部